• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    6.81 0.34(5.17%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:6.48
    Open:6.49
    Bid:0.01 x 100
    Ask:8.35 x 100
    1y Target Est:10.33
    Beta:3.33
    Earnings Date:Mar 2 - Mar 6 (Est.)
    Day's Range:6.46 - 6.85
    52wk Range:5.22 - 13.64
    Volume:353,306
    Avg Vol (3m):437,960
    Market Cap:297.64M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACRX

    Comparison

    Symbol% ChgMkt Cap
    ACRXUp 5.17%297.64M
    BAX38.42B
    CFN12.20B
    HSP11.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):8.68
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.95
    Quarterly EPS Est (Dec-14) :-0.30
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback